BTAI
Price
$1.99
Change
+$0.07 (+3.65%)
Updated
Apr 2 closing price
Capitalization
10.92M
39 days until earnings call
INO
Price
$1.66
Change
+$0.16 (+10.67%)
Updated
Apr 2 closing price
Capitalization
60.87M
Ad is loading...

BTAI vs INO

Header iconBTAI vs INO Comparison
Open Charts BTAI vs INOBanner chart's image
BioXcel Therapeutics
Price$1.99
Change+$0.07 (+3.65%)
Volume$97.48K
Capitalization10.92M
Inovio Pharmaceuticals
Price$1.66
Change+$0.16 (+10.67%)
Volume$847.24K
Capitalization60.87M
BTAI vs INO Comparison Chart
Loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BTAI vs. INO commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Hold and INO is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (BTAI: $1.99 vs. INO: $1.66)
Brand notoriety: BTAI: Not notable vs. INO: Notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 2% vs. INO: 118%
Market capitalization -- BTAI: $10.92M vs. INO: $60.87M
BTAI [@Biotechnology] is valued at $10.92M. INO’s [@Biotechnology] market capitalization is $60.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileINO’s FA Score has 0 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • INO’s FA Score: 0 green, 5 red.
According to our system of comparison, INO is a better buy in the long-term than BTAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 5 TA indicator(s) are bullish while INO’s TA Score has 4 bullish TA indicator(s).

  • BTAI’s TA Score: 5 bullish, 3 bearish.
  • INO’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BTAI is a better buy in the short-term than INO.

Price Growth

BTAI (@Biotechnology) experienced а -8.72% price change this week, while INO (@Biotechnology) price change was -5.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.69%. For the same industry, the average monthly price growth was -9.74%, and the average quarterly price growth was -14.08%.

Reported Earning Dates

BTAI is expected to report earnings on May 12, 2025.

INO is expected to report earnings on May 08, 2024.

Industries' Descriptions

@Biotechnology (-7.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INO($60.9M) has a higher market cap than BTAI($10.9M). INO YTD gains are higher at: -6.742 vs. BTAI (-66.736). BTAI has higher annual earnings (EBITDA): -56.15M vs. INO (-109.89M). BTAI has more cash in the bank: 233M vs. INO (84.8M). INO has less debt than BTAI: INO (12.4M) vs BTAI (105M). BTAI has higher revenues than INO: BTAI (2.28M) vs INO (203K).
BTAIINOBTAI / INO
Capitalization10.9M60.9M18%
EBITDA-56.15M-109.89M51%
Gain YTD-66.736-6.742990%
P/E RatioN/AN/A-
Revenue2.28M203K1,121%
Total Cash233M84.8M275%
Total Debt105M12.4M847%
FUNDAMENTALS RATINGS
BTAI vs INO: Fundamental Ratings
BTAI
INO
OUTLOOK RATING
1..100
8455
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
60
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9593
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INO's Valuation (60) in the Medical Specialties industry is in the same range as BTAI (82) in the Biotechnology industry. This means that INO’s stock grew similarly to BTAI’s over the last 12 months.

INO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as BTAI (100) in the Biotechnology industry. This means that INO’s stock grew similarly to BTAI’s over the last 12 months.

INO's SMR Rating (98) in the Medical Specialties industry is in the same range as BTAI (100) in the Biotechnology industry. This means that INO’s stock grew similarly to BTAI’s over the last 12 months.

INO's Price Growth Rating (93) in the Medical Specialties industry is in the same range as BTAI (95) in the Biotechnology industry. This means that INO’s stock grew similarly to BTAI’s over the last 12 months.

INO's P/E Growth Rating (100) in the Medical Specialties industry is in the same range as BTAI (100) in the Biotechnology industry. This means that INO’s stock grew similarly to BTAI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BTAIINO
RSI
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 1 day ago
68%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 28 days ago
82%
Bullish Trend 18 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
BTAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASST0.550.03
+5.77%
Asset Entities Inc.
UTI26.850.88
+3.39%
Universal Technical Institute
MAS71.061.22
+1.75%
Masco Corp
APAM40.220.61
+1.54%
Artisan Partners Asset Management
ACU40.390.55
+1.38%
Acme United Corp

BTAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, BTAI has been loosely correlated with ORMP. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if BTAI jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BTAI
1D Price
Change %
BTAI100%
+3.65%
ORMP - BTAI
44%
Loosely correlated
+3.29%
AXON - BTAI
42%
Loosely correlated
+3.18%
INO - BTAI
39%
Loosely correlated
+10.67%
IGMS - BTAI
38%
Loosely correlated
+6.96%
ARRY - BTAI
37%
Loosely correlated
+1.65%
More

INO and

Correlation & Price change

A.I.dvisor indicates that over the last year, INO has been loosely correlated with RPTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if INO jumps, then RPTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INO
1D Price
Change %
INO100%
+10.67%
RPTX - INO
57%
Loosely correlated
+4.90%
AXON - INO
53%
Loosely correlated
+3.18%
ARRY - INO
52%
Loosely correlated
+1.65%
ONCO - INO
50%
Loosely correlated
+4.76%
BCYC - INO
50%
Loosely correlated
+2.55%
More